Voya Investment Management LLC Sells 3,983 Shares of STERIS plc $STE

Voya Investment Management LLC cut its stake in STERIS plc (NYSE:STE – Free Report) by 2.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 163,308 shares of the medical equipment provider’s stock after selling 3,983 shares during the period. Voya Investment Management LLC owned approximately 0.17% of STERIS worth $34,296,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. NewEdge Advisors LLC grew its holdings in shares of STERIS by 0.7% during the 2nd quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock valued at $1,710,000 after purchasing an additional 56 shares during the last quarter. Taylor Frigon Capital Management LLC boosted its holdings in shares of STERIS by 0.9% during the 3rd quarter. Taylor Frigon Capital Management LLC now owns 6,505 shares of the medical equipment provider’s stock worth $1,366,000 after buying an additional 58 shares in the last quarter. Strengthening Families & Communities LLC grew its position in shares of STERIS by 0.6% during the 3rd quarter. Strengthening Families & Communities LLC now owns 10,884 shares of the medical equipment provider’s stock worth $2,286,000 after buying an additional 61 shares during the period. Mather Group LLC. increased its stake in shares of STERIS by 14.4% in the 3rd quarter. Mather Group LLC. now owns 565 shares of the medical equipment provider’s stock valued at $119,000 after acquiring an additional 71 shares in the last quarter. Finally, Community Financial Services Group LLC grew its stake in STERIS by 50.0% in the third quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 72 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Insider Activity at STERIS

In other STERIS news, CFO Karen Burton sold 5,880 shares of the business’s stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $255.62, for a total value of $1,503,045.60. Following the sale, the chief financial officer directly owned 12,956 shares of the company’s stock, valued at approximately $3,311,812.72. The trade was a 31.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Mohsen Sohi sold 4,893 shares of the stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $253.22, for a total transaction of $1,239,005.46. Following the sale, the director directly owned 24,305 shares in the company, valued at $6,154,512.10. This trade represents a 16.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 12,819 shares of company stock valued at $3,274,011 in the last 90 days. Corporate insiders own 1.12% of the company’s stock.

STERIS Stock Down 1.8%

Shares of NYSE STE opened at $254.93 on Friday. The company has a market cap of $24.76 billion, a price-to-earnings ratio of 23.84 and a beta of 0.86. The firm’s fifty day moving average is $226.54 and its 200 day moving average is $224.53. The company has a quick ratio of 1.44, a current ratio of 2.05 and a debt-to-equity ratio of 0.23. STERIS plc has a 52 week low of $195.14 and a 52 week high of $269.44.

STERIS (NYSE:STE – Get Free Report) last posted its earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.68 by $0.26. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.56 billion. STERIS had a return on equity of 14.80% and a net margin of 13.41%. STERIS’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period last year, the firm earned $2.47 earnings per share. On average, equities research analysts expect that STERIS plc will post 11.46 earnings per share for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be given a $0.69 dividend. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, November 17th. STERIS’s payout ratio is currently 32.74%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on STE. Morgan Stanley upgraded STERIS from an “overweight” rating to a “buy” rating in a report on Friday, November 13th. UBS Group reduced their target price on shares of STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Weiss Ratings upgraded STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, November 9th. Piper Sandler reissued an “overweight” rating and set a $275.00 price objective (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. Finally, KeyCorp raised their price target on STERIS from $269.00 to $284.00 and gave the company an “overweight” rating in a report on Friday, November 6th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average target price of $283.50.

Get Our Latest Stock Analysis on STE

About STERIS

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Featured Articles

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.